Merus N.V.

Industry

  • Biotechnology
    • Large Molecule
      • Antibodies
    • Drug Discovery Technologies
    • Antisense, Oligonucleotides
    • Transgenics
  • Pharmaceuticals

Other Names/Subsidiaries

  • Merus B.V.
  • Merus BV
  • Merus NV
  • Merus US, Inc.
See more in Biomedtracker

Latest on Merus N.V.

In Vivo

Hans Clevers' Vision For The Future Of Drug Development And Personalized Medicine

 
• By David Wild

When Hans Clevers took the helm of Pharma Research and Early Development (pRED) at Roche, he faced a unique challenge: scaling the leadership principles he had developed running a 35-person academic l

Scrip

Deal Watch: Bausch Companies Set Hectic Pace At J.P. Morgan With Five Deals

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. B+L Bolsters Ophthalmology With Acquis

Scrip

Deal Watch: GSK Extends Its Shingrix Alliance In China With Zhifei

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Zhifei Commits To Acquiring $2.93bn Of

Pink Sheet

US FDA’s November Goal Dates Cannot Elevate 2024’s Novel Approvals To 2023 Levels

 
• By Bridget Silverman

With only six novel candidates on its November 2024 user fee calendar, the US Food and Drug Administration is running out of chances to reach its 2023 total of 72 new molecular entities and novel biol